References
- Randolph SA. Ischemic stroke. Workplace Health Saf. 2016;64(9):444.
- Larsson A, Karlsson C, Rentzos A, et al. Do patients with large vessel occlusion ischemic stroke harboring prestroke disability benefit from thrombectomy? J Neurol. 2020;267(9):2667–2674. DOI:10.1007/s00415-020-09882-5
- Ma J, Shui S, Han X, et al. microRNA-200a silencing protects neural stem cells against cerebral ischemia/reperfusion injury. PLoS One. 2017;12:e0172178.
- Buckley A, Hagler SB, Lettry V, et al. Generation and profiling of tumor-homing induced neural stem cells from the skin of cancer patients. Mol Ther. 2020:28(7):1614–1627. DOI:10.1016/j.ymthe.2020.04.022
- Lin CQ, Chen LK. Cerebral dopamine neurotrophic factor promotes the proliferation and differentiation of neural stem cells in hypoxic environments. Neural Regen Res. 2020;15(11):2057–2062.
- Liu Q, Li Y, Zhou L, et al. GRP78 promotes neural stem cell antiapoptosis and survival in response to oxygen-glucose deprivation (Ogd)/reoxygenation through PI3K/Akt, ERK1/2, and NF-kappaB/p65 pathways. Oxid Med Cell Longev. 2018;3541807. DOI:10.1155/2018/3541807
- Wang J, Hu Y, Ye C, et al. miR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting SND1. Hum Cell. 2020;33(3):780–789. DOI:10.1007/s13577-020-00364-4.
- Xue WS, Wang N, Wang NY, et al. miR-145 protects the function of neuronal stem cells through targeting MAPK pathway in the treatment of cerebral ischemic stroke rat. Brain Res Bull. 2019;144:28–38.
- Wang J, Wang G, Li B, et al. miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma. Onco Targets Ther. 2018;11:4461–4478.
- Li M, Huang H, Cheng F, et al. Promotes proliferation and metastasis of nasopharyngeal carcinoma by targeting NME1. Adv Med Sci. 2020;65(2):252–258. miR-141-3p. DOI:10.1016/j.advms.2020.03.005.
- Guan G, Niu X, Qiao X, et al. Upregulation of Neural Cell Adhesion Molecule 1 (NCAM1) by hsa-miR-141-3p suppresses ameloblastoma cell migration. Med Sci Monit. 2020;26:e923491.
- Verma R, Ritzel RM, Harris NM, et al. Inhibition of miR-141-3p ameliorates the negative effects of poststroke social isolation in aged mice. Stroke. 2018;49:1701–1707.
- Zuo X, Lu J, Manaenko A, et al. MicroRNA-132 attenuates cerebral injury by protecting blood-brain-barrier in MCAO mice. Exp Neurol. 2019;316:12–19.
- Zhang W, Gu GJ, Zhang Q, et al. NSCS promote hippocampal neurogenesis, metabolic changes and synaptogenesis in APP/PS1 transgenic mice. Hippocampus. 2017;27(12):1250–1263. DOI:10.1002/hipo.22794
- Villaescusa JC, Li B, Toledo EM, et al. A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson’s disease. Embo J. 2016;35(18):1963–1978. DOI:10.15252/embj.201593725
- Xu X, Zhou Y, Fu B, et al. PBX1 promotes development of natural killer cells by binding directly to the Nfil3 promoter. Faseb J. 2020;34(5):6479–6492. DOI:10.1096/fj.202000121R
- Zhou Y, Fu B, Xu X, et al. PBX1 expression in uterine natural killer cells drives fetal growth. Sci Transl Med. 2020;12(537):eaax1798. DOI:10.1126/scitranslmed.aax1798
- Lattanzi R, Maftei D, Petrella C, et al. Involvement of the chemokine prokineticin-2 (PROK2) in Alzheimer’s disease: from animal models to the human pathology. Cells. 2019;8(11):1430. DOI:10.3390/cells8111430
- Kurebayashi H, Goi T, Shimada M, et al. Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer. Oncotarget. 2015;6:26242–26251.